High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

Back

ESC Professional Premium Access

High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

Session: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Topic: Aortic Valve Intervention

Speaker: Doctor J. Strange (Copenhagen, DK)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Jarl Emanuel Strange

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 follower

6 more presentations in this session

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Speaker: Doctor V. Panoulas (Harefield, Uxbridge, GB)

Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR

Speaker: Doctor P. Jimenez-Quevedo (Madrid, ES)

High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation

Speaker: Doctor D. Hesselbarth (Freiburg, DE)

Impact of visceral adipose tissue on mortality in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor A. Somaschini (Savona, IT)

Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry

Speaker: Doctor K. Nilsson (Uppsala, SE)

Access the full session

TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Speakers: Doctor J. Strange, Doctor V. Panoulas, Doctor P. Jimenez-Quevedo, Doctor D. Hesselbarth, Doctor A. Somaschini...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

About the speaker

Doctor Jarl Emanuel Strange

6 more presentations in this session

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR

High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation

Impact of visceral adipose tissue on mortality in patients undergoing transcatheter aortic valve implantation

Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry

Access the full session

TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

About the event

ESC Congress 2023

ESC 365 is supported by